H2020FP7HORIZON
Genexplain GmbH
- Country
- DEGermany
- Defence projects
- 0
- Projects, all programmes
- 12
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 4,542,010
- Active
- 2011 to 2023
Projects
12 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| Chrom_rareUnveiling the molecular basis of chromatinopathies to delineate innovative therapeutic solutions | HORIZON | 2023 | Participant | EUR 260,539 |
| HIT-GLIOTargeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy | HORIZON | 2023 | Participant | EUR 1,008,750 |
| GLIORESOLVETraining the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment | HORIZON | 2022 | Participant | EUR 260,539 |
| PD-MitoQUANTPD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease | H2020 | 2019 | Participant | EUR 147,921 |
| COLOSSUSAdvancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions | H2020 | 2018 | Participant | EUR 281,865 |
| GLIOTRAINExploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics | H2020 | 2017 | Participant | EUR 249,216 |
| OPTOGENERAPYOptogenetic Protein Therapy for Multiple Sclerosis | H2020 | 2017 | Participant | EUR 386,100 |
| miRNA-DisEASYmicroRNA biomarkers in an innovative biophotonic sensor kit for high-specific diagnosis | H2020 | 2015 | Participant | EUR 18,000 |
| RESOLVEA systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol | FP7 | 2013 | Participant | EUR 584,599 |
| SYSMEDIBDSystems medicine of chronic inflammatory bowel disease | FP7 | 2012 | Participant | EUR 499,960 |
| MIMOMICSMethods for Integrated analysis of Multiple Omics datasets | FP7 | 2012 | Participant | EUR 347,800 |
| SYSCOLSystems Biology of Colorectal Cancer | FP7 | 2011 | Participant | EUR 496,720 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.